6699 — Angelalign Technology Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Angelalign Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	fx Final	fx Final	Final	Final	Final
Revenue
Total Revenue	197	189	210	269	370
Cost of Revenue
Gross Profit	128	117	131	168	233
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	148	157	214	263	340
Operating Profit	49.3	31.4	-3.93	6.28	30.6
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	51.5	37.4	8.58	11.7	31.7
Provision for Income Taxes
Net Income After Taxes	44.3	31.7	6.83	10	26.3
Minority Interest
Net Income Before Extraordinary Items
Net Income	44.3	31.8	7.53	12.1	28.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	44.3	31.8	7.53	12.1	28.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.307	0.188	0.045	0.072	0.21
Dividends per Share
Special Dividends per Share